BOSTON, February 7, 2023 /PRNewswire/ -- BrickBio Highlights Unique Advantages from the Proprietary "VADER" System, published on Dec 22,...

BOSTON, April 25, 2022 /PRNewswire/ -- BrickBio Highlights Powerful Advantage of the Company's BrickADCs™, Protein Origami™, and...

BOSTON, Nov. 2, 2021 /PRNewswire/ -- BrickBio, the leader in site-specific bioconjugation, announced a rapid next-generation conjugation...

BOSTON, Oct. 26, 2021 /PRNewswire/ -- A Rapid Predictive Site-Selection Panel for ADC-Linker-Payload Optimization BrickBio, the leader in...

BOSTON, Jan. 19, 2021 /PRNewswire/ -- The leader in site specific bioconjugation and DAR (drug to antibody ratio) optimization in...

BOSTON, Jan. 6, 2021 /PRNewswire/ -- BrickBio, the leading company in site-specific bioconjugation for improved therapeutics, has signed...

The company is developing biologics across three internal programs BOSTON, Nov. 10, 2020 /PRNewswire/ -- The leading company in...

BrickBio has made robust its novel site-specific conjugation process of inserting unnatural amino acids at any site within a protein or...

BOSTON, Jan. 22, 2020 /PRNewswire/ -- BrickBio Inc., the leading company in site specific, single and multi-site bioconjugation of...

- BrickBio’s technology enables efficient placement of unnatural amino acids into recombinant antibodies at specific sites - Together,...

Boston, Massachusetts – BrickBio, a protein engineering company formed out of the Chatterjee Lab at Boston College and backed by Tiger...

Boston, Massachusetts – BrickBio, the Tiger Gene backed protein and antibody modification company, announced today that Dr. James Italia,...

Boston, Massachusetts - BrickBio, a company formed out of Tiger Gene has obtained a worldwide exclusive license, from Boston College, to...